Navigation Links
AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
Date:5/30/2008

riatr Pharmacother 2006;4(3):244-50.

(10) Barkun et al. The cost-effectiveness of high-dose oral proton pump

inhibition after endoscopy in the acute treatment of peptic ulcer

bleeding. Aliment Pharmacol Ther 2004; 20: 195-202.

(11) Barkun et al. High-dose intravenous proton pump inhibition following

endoscopic therapy in the acute management of patients with bleeding

peptic ulcers in the USA and Canada: a cost-effectiveness analysis

Aliment Pharmacol Ther 2004; 19: 591-600.


'/>"/>
SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
2. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
3. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
4. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
5. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
6. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
7. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
8. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
9. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
10. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
11. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... noviembre de 2014  BioClinica®, Inc., un proveedor ... tecnologías eClinical, ha indicado un aumento de la ... el seguimiento basado en el riesgo en los ... del seguimiento basado en el riesgo más allá ... seguimiento o cambio de los métodos de seguimiento. ...
(Date:11/22/2014)... Pa. , Nov. 21, 2014  Particle ... eluting devices, has developed and manufactured a new ... (LPRI), the Research and Development arm of Exeltis ... President of Project Management at Particle Sciences, "This ... Sciences utilizing our material sciences and modeling expertise.  ...
(Date:11/21/2014)... , Nov. 21, 2014  The University of Maryland,s ... the ceremonial groundbreaking of the new A. James Clark ... new building will cultivate transformative new engineering and biomedical ... Taking place at 10:00 a.m. on November 21 at ... Branch Parking Lot, adjacent to the Jeong H. Kim ...
Breaking Medicine Technology:El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4
(Date:11/23/2014)... November 23, 2014 Syngenta lawsuits are ... behalf of farmers and agribusinesses that have allegedly incurred ... commercialize Agrisure Viptera and Agrisure Duracade, genetically modified ... approved for sale in China. According to a report ... virtually ban U.S. corn imports. Because China is the ...
(Date:11/23/2014)... Lake City, Utah (PRWEB) November 23, 2014 ... individual health insurance reimbursement for small businesses, announced ... new book, The End of Employer-Provided Health Insurance. ... health insurance is the greatest financial risk facing ... challenge facing U.S. employers, small and large, when ...
(Date:11/22/2014)... Cancer researchers in New York and Minnesota ... tunnels and the growth and spread of mesothelioma. ... the Surviving Mesothelioma website. , Doctors at Memorial ... have just released their study on tunneling nanotubes (TnTs), ... They found that mesothelioma cells contain many ...
(Date:11/22/2014)... A classic black prom dress will never go out of ... unveiled its new items of black prom gowns . ... big discount, up to 70% off. People throughout the world ... prom dresses, made with the best materials, can make wearers ... customers, the company provides these beautiful outfits in a huge ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding ... the business offers a wide range of special occasion ... allowing them to create multiple looks easily. , According ... collection of chic wedding dresses has been prepared for ... discounted rates now. Dylan Queen can always create what ...
Breaking Medicine News(10 mins):Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2
... SHENZHEN, China, Sept. 21 /PRNewswire-Asia/ -- ... or the "Company"), a leading,exporter of medical dressing and ... sponsored the "2009 China Medical Textile Industry,Forum -- Innovation ... China. , The organizer of ...
... , , LINCOLN, R.I., Sept. 21 ... Americans report problems with chronic pain; more than diabetes, heart disease, ... of chronic pain in the United States, including healthcare expenses, lost ... , "Despite the obvious impact on our society and ...
... , , BIRMINGHAM, Ala., ... today announced that it has been awarded a $77.2 million contract ... to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous ... , "We are very excited to continue working ...
... , PRINCETON, N.J., Sept. 21 ... Company), a late-stage biotechnology company, announced today that it has ... Institute of Allergy and Infectious Diseases (NIAID), a division of ... over a five-year period, the development of formulation and manufacturing ...
... , , INDIANAPOLIS, Sept. 21 ... in nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who ... care as compared to placebo plus best supportive care. ... previous studies looking at the use of histology to tailor treatment ...
... , , , ... today announced U.S. Food & Drug Administration clearance to market ... is the first and only blood glucose monitor that plugs ... information that can help optimize diabetes management. The CONTOUR USB ...
Cached Medicine News:Health News:Winner Medical Solely Sponsored the 2009 China Medical Textile Industry Forum 2Health News:Winner Medical Solely Sponsored the 2009 China Medical Textile Industry Forum 3Health News:Measuring Pain from the Patient's Point of View 2Health News:BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza 2Health News:BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza 3Health News:BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza 4Health News:BioCryst Awarded Additional $77.2 Million by the U.S. Department of Health & Human Services To Develop Peramivir for Influenza 5Health News:DOR BioPharma Announces $9.4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 2Health News:DOR BioPharma Announces $9.4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 3Health News:DOR BioPharma Announces $9.4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 4Health News:DOR BioPharma Announces $9.4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 5Health News:DOR BioPharma Announces $9.4 Million NIH Grant Award to Develop Thermostable and Rapidly Acting Vaccines 6Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 2Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 3Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 4Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 5Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 6Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 7Health News:Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 8Health News:Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play Diabetes Management Software 2Health News:Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play Diabetes Management Software 3Health News:Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play Diabetes Management Software 4Health News:Bayer Introduces CONTOUR USB - The First Blood Glucose Meter With Unique Plug & Play Diabetes Management Software 5
... Pediatric Sarmiento-style PTB tibial orthosis ... Lined with closed-cell foam at bony ... Selection of 3 modular footpiece/shoe insert ... patient. Stretch Velcro® design fits especially ...
... is a lightweight patient friendly brace utilizing the ... The Escort provides patients with a lightweight ... Superior comfort and improved patient compliance is ... Escort Hip brace is the result of ...
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
Modular hip abduction system designed to provide superior fit, adjustability and functionality for optimum patient stability, comfort and compliance...
Medicine Products: